These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9460601)

  • 1. [Comparative study of permeability of derivatives of gamma-aminobutyric and gamma-hydroxybutyric acids through hemato-encephalic barrier].
    Nasybullina NM; Zherdev VP; Gunar VI; Kopelevich VM; Kozlova GS
    Eksp Klin Farmakol; 1997; 60(6):52-4. PubMed ID: 9460601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the permeability across the hemato-encephalic barrier and of the effect on cerebral blood flow of the new neurotropic agent calcium ketohomopantothenate and of pantogam].
    Nasybullina NM; Gunar VI; Zherdev VP; Sariev AK; Kozlova GS; Mirzoian RS; Gan'shina TS; Karaev AL
    Eksp Klin Farmakol; 1997; 60(2):58-61. PubMed ID: 9206573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of the nootropic drugs].
    Boĭko SS; Vitskova GIu; Zherdev VP
    Eksp Klin Farmakol; 1997; 60(6):62-70. PubMed ID: 9460604
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved delivery through biological membranes. XXI. Brain-targeted anti-convulsive agents.
    Woodard PA; Winwood D; Brewster ME; Estes KS; Bodor N
    Drug Des Deliv; 1990 May; 6(1):15-28. PubMed ID: 2078285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo.
    Gobaille S; Hechler V; Andriamampandry C; Kemmel V; Maitre M
    J Pharmacol Exp Ther; 1999 Jul; 290(1):303-9. PubMed ID: 10381791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluorothane pharmaco kinetics in brain structures and the permeability of the hemato-encephalic barrier in postnatal ontogeny].
    Fateev VA; Saliaev VN; Titov NS
    Farmakol Toksikol; 1980; 43(1):41-3. PubMed ID: 7379989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intake dynamics of GABA and its pantoate derivative in mice brain areas].
    Rozanov VA; Kopelevich VM; Savits'kiĭ IV; Rozanov AIa
    Ukr Biokhim Zh; 1977; 49(6):34-8. PubMed ID: 929708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemato-encephalic barrier. Structural, functional and physiopathological data].
    Badiu G
    Stud Cercet Neurol; 1966; 11(1):51-79. PubMed ID: 5326584
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoenzyme detection of specific brain antigens as a criterion of the permeability of the hemato-encephalic barrier in rats following acute gamma irradiation].
    Chekhonin VP; Morozov GV; Riabukhin IA
    Biull Eksp Biol Med; 1989 Apr; 107(4):464-6. PubMed ID: 2470443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.
    Bhattacharya I; Boje KM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):92-8. PubMed ID: 15173314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of 1-[14C] GABA and its conjugates with nicotinate, pyridoxal phosphate and biotin in tissues of guinea pigs in closed systems].
    Tyshchenko DV; Rozanova ZA
    Fiziol Zh (1978); 1993; 39(4):33-8. PubMed ID: 8243713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased brain uptake and brain to blood efflux transport of 14C-GABA in spontaneously hypertensive rats.
    Al-Awadi M; Pavlik A; Al-Sarraf H
    Life Sci; 2006 Jul; 79(9):847-53. PubMed ID: 16616765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and electrophysiological differences between gamma-hydroxybutyric acid and GABA-mimetic drugs.
    Ostrovskaya RU
    Ann Ist Super Sanita; 1982; 18(1):91-4. PubMed ID: 7171177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative analysis of electrical brain activity after GABA and glutamate administration: is it possible to have correlation between specific neurochemical changes in the brain and in the EEG?].
    Iarkov AV; Gal'chenko VV; Kovalev GI
    Biull Eksp Biol Med; 1997 Aug; 124(8):174-7. PubMed ID: 9410203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental and clinical data on the ability of bemetil to penetrate the hemato-encephalic barrier].
    Boĭko SS; Bobkov IuG; Dobrokhotova TA; Kniazeva NA; Neznamov GG
    Farmakol Toksikol; 1987; 50(3):79-81. PubMed ID: 3609285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of a method of mathematical analysis in studying the permeability of the hemato-encephalic barrier in bacterial meningoencephalitis].
    Iarosh OA
    Vrach Delo; 1991 Nov; (11):69-73. PubMed ID: 1801440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pikamilon pharmacokinetics in animals].
    Dorofeev BF; Kholodov LE
    Farmakol Toksikol; 1991; 54(2):66-9. PubMed ID: 1884802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat.
    Stolp HB; Dziegielewska KM; Ek CJ; Potter AM; Saunders NR
    Eur J Neurosci; 2005 Dec; 22(11):2805-16. PubMed ID: 16324115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the permeability of the hemato-encephalic barrier in mental patients using P 32].
    Utrata R; Svacina J; Drahozal H; Skrivánek O
    Cesk Psychiatr; 1967 Dec; 63(6):389-96. PubMed ID: 6080263
    [No Abstract]   [Full Text] [Related]  

  • 20. GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.
    Takanaga H; Ohtsuki S; Hosoya Ki ; Terasaki T
    J Cereb Blood Flow Metab; 2001 Oct; 21(10):1232-9. PubMed ID: 11598501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.